Yara Al Mouti is a pharmaceutical consultant and trainer with more than 19years of experience. She has an extensive background in all matters related to cGMP, GSDP and Quality Management systems. She is an analytical and conceptual thinker who effectively partners with senior managers to assess current statuses, facilitate strategic decisions, and drive successful implementations. Yara has foundedAgon Consultsince 2011. Prior to starting Agon up, she worked extensively as a project manager as well as a quality and validation engineer in several pharmaceutical companies. She holds a Bachelors's degree in chemical engineering from Al-Balqa University in Amman, Jordan.
Talk title: Cost benefit of investment on quality in pharmaceutical manufacturing
Talk title: Data Integrity Roadmap
Talk title: Quality Metrics
Talk title: Risk-Based cleaning validation
Talke title: EU Accreditation (challenges, needs and benefits)
Dr. Aigbogun has extensive industrial and theoretical experience in security, risk, and regulatory compliance of pharmaceutical products. His scientific findings, coming from his vast experience working in the various arms of the pharmaceutical industry, and as a research scientist, have been published in peer-reviewed journals and Newspaper columns. He has a PhD in Management with specialization in pharmaceutical supply chain resilience. He currently holds the position of a Senior Lecturer and Programme Leader at a 5-star rated Business and Management University where he lectures students from diverse nationalities, directs a number of research projects, and sits on the examination board for doctoral candidates.
Talk title: Pharmaceutical Supply Chain response/ resilience during and after the COVID-19
Dr Meriem HEDIBEL, 35 years old, assistant professor at the University of Algiers. After completing her post-graduation studies in 2012, she began her career in the Ministry of Health at the Pharmaceuticals’s Directorate where she was in charge of investment projects, managing pharmacovigilance activity, and drafting regulatory framework related to pharmaceuticals. In 2015, she started teaching pharmaceutical technology at the pharmacy department at the university, she, then joined Pasteur Institute of algeria where she held the feeling-packaging department head position. In 2017 she returned to the Ministry of Health, where she served as the deputy director of hospital pharmacy.
Talk title: Pricing Dilemma
With over +12 years of experience in cGMP, improving quality management systems, and providing large-scale on-site support to meet the recent standards and global trends, Ayat Alkhatib is capable of solving problems using various engineering and analytical criteria which all together make her an essential strong member at Agon. Eng. Ayat AlKhatib is an experienced project manager with an established history of working in the pharmaceutical industry. During her career, she has honed her skills in Quality management systems, Quality Auditing, Validation, and project management professional. SQA associate as senior lead auditor.
Talk title: Business Continuity Plan – A practical Approach for the upcoming crisis
Florian Hildebrand is a visionary Tech-Entrepreneur and Co-Founder of Qualifyze, an online platform for supplier audits. During the COVID pandemic, he helped to double the company to over 35 employees, made seven-digit annual revenue, and created a global customer base. Especially during the pandemic, with their global approach, Qualifyze was able to help pharmaceutical companies to keep their critical drug supply intact to deliver medicine to patients globally.
Talk title: Leadership lessons shifting mindset and rebounding from adversity in a crisis
Health products like medicines and diagnostics can save and improve lives—but only if patients can access them in moments of need. The global health community also emphasizes the transformative potential of these technologies to fight scourges like HIV, malaria, and tuberculosis (TB), and to achieve the health-related Sustainable Development Goals (SDGs). Yet these potential gains can only be realized with strong systems to prioritize and procure cost-effective lifesaving health products and ensure they are available at affordable prices to those who need them most at the quality expected. Three trends become easily obvious:
Jessica Jones is a program officer for market dynamics and systems innovations at the Bill & Melinda Gates foundation. In this role, she develops and manages grants that use market tools to increase sustainable access to key medicines, diagnostics, and medical devices for low-income populations with a focus on maternal and neonatal health, as well as build the field of market dynamics for health technologies. Prior to joining the foundation in January 2014, Jessica had a 15-year career across development and economics in the D.C.-area, including the African Regional Integration department of the World Bank and the National Center for Environmental Economics at the U.S. Environmental Protection Agency. She has a passion for using an economics toolkit across multiple sectors for the benefit of the world’s most vulnerable.
Bolaji Oladejo, is the out-going Director of Policy & Plan, Federal Ministry of Health, Nigeria. During his civil service career spanning over 30 years largely in the health sector, he had varied responsibilities that cut across development, monitoring and evaluation of health policies, plans, programmes, and projects; Health Management Information System (HMIS); Human Resources for Health; Health Care Financing; Health Research; International Cooperation; Health Systems Management; and Public-Private Partnership. He had the opportunity of serving as Liaison Officer for the West African Health Organization (WAHO); Principal Investigator, World Bank-Funded Nigeria State Health Investment Project (WB-NSHIP); and Project Team Coordinator, Health Information System Component of the Global Fund Resilient and Sustainable Systems for Health (GF-RSSH) Project. Before joining civil service, he had worked briefly with a French multinational (SCOA Motors, Lagos) as Assistant Leasing Manager.
Mr. Joshua Phoho Setipa assumed the role of Managing Director for The Technology Bank for Least Developed Countries in November 2018. With over 20 years’ experience in senior roles on international trade, economic policy, investment strategy and economic development at the national, regional and multilateral levels, Mr. Setipa has a wealth of experience and knowledge on issues affecting least developed countries. Mr. Setipa comes to The Technology Bank from the from The World Bank where he has been leading strategic engagements with West Africa.
Bankole Eniola is the Director of Project finance for DFS Africa. He has over 12 years’ experience in investment banking and project financing in leading financial services organisations such as HSBC, UBS, Deutsche Bank, Lloyds Banking Group and Royal Bank of Scotland. Bankole's fields of expertise include Deal Origination and Structuring, Strategic Planning, Risk Analysis, Financial Modelling, Transaction Structuring and Deal Execution. Bankole’s core deliverables over the last decade includes setting up several public‐private partnerships, design of public procurement processes in infrastructure financing, pricing and regulation of infrastructure services; public and private sector performance monitoring and macroeconomic and fiscal performance evaluation.
Olakunle Olaniyi-Edwards is an Executive Director and Co-Founder at DFS Africa, a Pan Africa Transaction advisory firm, with a bias for Pharmaceuticals, Financial Services and FCMG. He also leads the Transactions side of the Business. His experience cuts across the Financial Sector, Extractive Industries and Public Sector financing. His field of expertise hinges on core understandings of Financial Theories (Risk, Returns -Expected and Actual, Capital Allocation, Capital Structure, Pricing and Valuation), Financial Markets (Cash/Money, Equity, Debt and Derivatives markets), and Financial Products (Cash, Equity, Debt and Derivatives).
Dr. Janet Byaruhanga is a Senior Programme Officer, Public Health at the Africa Union Development Agency (AUDA-NEPAD). Janet is a qualified medical doctor and public health expert with extensive experience international development with special focus on human and social development sector, offering a track-record of performance, a strategic approach to achieving results, driven by the passion to contribute to the African Union’s vision for a United Peaceful, Integrated and Prosperous continent capable of playing its role in the global arena.
Roberto Bertini has more than 20 years’ experience long career in Computerised Systems Validation and Data Integrity assurance. He graduated in Physics at the University of “La Sapienza” in Rome, and he joined PQE in 2000. He is currently Operations Director at PQE for Europe and CIS Regions, where he is leading the service delivery related to the Business Lines for Data Integrity Assurance. He has managed the validation process of most common Computerised Systems used in the Life Science environment (e.g. ERP, MES, LIMS, WMS, Lab Systems, PCS, Serialization domain) and he has supported the implementation of Quality Management Systems for the IT governance.
Talk title: Data Integrity Roadmap
Talk title: EU Accreditation (challenges, needs, and benefits)
Dr Bawaresh currently is the Head of Rational Drug Use and Pharmacovigilance Department at Jordan Food and Drug Administration (JFDA). Dr Bawaresh worked in both the private and governmental sectors as a private pharmacist and hospital pharmacist, respectively. She started to work within the JFDA Pharmacovigilance Department in 2001. Dr Bawaresh has been working actively to promote the concept of pharmacovigilance within industrial companies and to motivate reporting of adverse drug reactions among healthcare providers (HCP) in Jordan.
Talk title: Pharmacovigilance and drug safety/Fraudulent activity.
Andreas Flückiger is an Occupational Toxicology and Containment for the Pharmaceutical Industry consultant & Professor at the Viennese Academy of Occupational Medicine and Prevention. He was previously the Chief Occupational Health Officer, F. Hoffmann-La Roche Ltd at Basel, responsible for occupational health and health promotion at the global level: risk assessments at the workplaces, occupational toxicology, setting health-based limit values for the workplace, and GMP cleaning, occupational medicine, occupational hygiene, radiation protection, biological safety, ergonomics, health promotion, etc.
Talk title: Manufacturing of Hazardous Products
Following her study at Westfaelische Wilhelms University in Germany, Fatma Taman has completed her Pharmacy study at Istanbul University. She has 28 years of experience in pharmaceutical manufacturing and management. Last one year as Chief Technical Officer of a Jordanian company MS Pharma for 4 plants in 3 countries in the MENA region, beforehand 6 years as General Manager of PharmaVision in Istanbul, Turkey. She also served as Site Director in total 10 years, at IE - Menarini Turkey, Eczacıbası -Zentiva, and Abdi İbrahim.
Talk title: The critically needed infrastructure for the pharmaceutical industry
Talk title: Shifting from local distribution strategy to export strategy
Rima Nsheiwat, is a pharmacist with 15 years of experience in regulatory activities in pharma industry. Through her career in the Arab Drugstore-Jordan, she successfully established and managed different operational departments such as supply chain, quality compliance, in addition to regulatory and intelligence department. Moreover, she was part of the teams responsible for revision of JFDA regulations, in addition to her active participation in many workshops and conferences. Her passion and dedication, along with her two master degrees (Public health and MBA), supported her remarkable achievements in different regulatory scopes.
Talk title: Products registration cycle
Mr. Ayush Nag the Jr. Manager of International Sales Kevision Systems Pvt. Ltd; India. He is a Mechanical Engineer with 4+ years of experience in the African pharmaceutical machinery sales.
Talk title: Dry Granulation in Oral Solid Dosage Processing & SERIALISATION: Prioritizing Consumer Safety & Driving Business Value
Talk title: Risk-Based cleaning validation
Mr. Parth Chokshi, is the Sr. Manager of International Sales at Kevin Process Technologies Pvt. Ltd; India. Parth is an MBA graduate with over 25 years of work experience and having 11 years of experience in the internatioanl pharmaceutical machinery sales.
Talk title: Dry Granulation in Oral Solid Dosage Processing & SERIALISATION: Prioritizing Consumer Safety & Driving Business Value
Mr. Nathan Nagel is a serial entrepreneur with 21 years’ global experience on the commercial side of medicine including 8 years working in MENA. In addition to being CEO of MEMP he is MD of Oncology Commercial Services and also has a portfolio of current board advisory positions in biotechnology and AI health tech companies. partner of LifeScience Ventures Ltd, a UK consulting company. Prior to leading companies, Nathan worked for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career.
Talk title: Market Access in the Covid Era
Elisa is a Policy Analyst for the Africa, Europe and Middle East Unit of the OECD Development Centre. She contributes to policy-oriented research and policy dialogue, notably through the flagship report Africa’s Development Dynamics of the African Union Commission and the OECD Development Centre. Elisa holds a Master’s Degree in International Economics from University Paris Nanterre. She speaks French and English.
Talk title: Development of African Value Chains and Pharmaceuticals
Dr. Fernando de Mora is a Professor of Pharmacology with a PhD in immunopharmacology from the University of Chicago MBA. He is also the Chairman of the Pharmacology Dept and the Principal Investigator in allergy projects. He holds a Postdoc at Harvard Medical School and also is an International consultant in biotech science, regulation and market for private/public organizations (e.g. MoH, United Nations, DIA) / Manager of academic spin-off biosimilars firm.
Talk title: Biotechnology and biosimilars
Jean-Baptiste is IAC Partners' healthcare practice leader. For more than 15 years, he has been leading time-to-market projects for major pharmaceutical and food-processing players in Europe and Asia.
Graduated from INSA Lyon and HEC Paris, he regularly lectures to engineering school students and supervises a thesis about Machine Learning applied to care protocols.
Talk title: Cost optimization/ time-to-market